Fed. Circ. Urged To Not Review Defense In $200M Patent Suit
Boston Scientific urged the Federal Circuit on Friday not to rethink a holding that the company is shielded from liability by the rarely invoked ensnarement defense in a cardiologist's contract suit...To view the full article, register now.
Already a subscriber? Click here to view full article